ArticleFrontiers in surgery2026
Association between postoperative silver sulfadiazine dressings and surgical site infection after skin cancer excision: an observational cohort study with historical controls.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Surgical site infections (SSIs) remain a relevant postoperative complication in dermatologic surgery, negatively affecting wound healing, patient outcomes, and healthcare costs. Although the baseline infection risk after clean skin cancer surgery is relatively low, preventive strategies remain clinically important. Silver sulfadiazine (SSD) is a topical antimicrobial agent with broad-spectrum antibacterial activity; however, its preventive role in clean oncologic dermatologic surgery remains insufficiently investigated. This study evaluated the association between postoperative SSD-based dressings and SSI occurrence after skin cancer excision. Methods: A non-randomized observational cohort study with a non-concurrent historical control group was conducted including 800 patients undergoing excision of basal cell carcinoma or squamous cell carcinoma. The intervention group ( Results: At T1, SSIs occurred in 36/400 patients (9.0%) in the SSD group compared with 72/400 patients (18.0%) in the control group (RR = 0.50; 95% CI: 0.34-0.73; Conclusion: Postoperative SSD-based dressings were associated with a lower incidence of early SSI after skin cancer excision. Because of the non-randomized design and the use of non-concurrent historical controls, the observed reduction should be interpreted as an association rather than proof of causality. Further prospective randomized studies are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.